These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8098643)

  • 1. Porphyria cutanea tarda associated with methotrexate therapy.
    O'Neill T; Simpson J; Smyth SJ; Lovell C; Calin A
    Br J Rheumatol; 1993 May; 32(5):411-2. PubMed ID: 8098643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyria cutanea tarda affecting a rheumatoid arthritis patient treated with methotrexate: association or coincidence?
    Chalem P; Ghnassia AM; Nordmann Y; Menkes CJ
    Rheumatology (Oxford); 1999 May; 38(5):453-6. PubMed ID: 10371285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provocation of porphyria cutanea tarda by KUVA-therapy of vitiligo.
    Jansen T; Megahed M; Hölzle E; Plewig G
    Acta Derm Venereol; 1995 May; 75(3):232-3. PubMed ID: 7653185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term followup of naproxen-induced pseudoporphyria in juvenile rheumatoid arthritis.
    Mehta S; Lang B
    Arthritis Rheum; 1999 Oct; 42(10):2252-4. PubMed ID: 10524703
    [No Abstract]   [Full Text] [Related]  

  • 6. Sclerodermiform porphyria cutanea tarda after torasemide.
    Kranzelbinder B; Wiednig M; El-Shabrawi-Caelen L; Aberer W; Aberer E
    Eur J Dermatol; 2015; 25(5):484-5. PubMed ID: 26693635
    [No Abstract]   [Full Text] [Related]  

  • 7. Porphyria cutanea tarda induced by tamoxifen.
    Cruz MJ; Alves S; Baudrier T; Azevedo F
    Dermatol Online J; 2010 Sep; 16(9):2. PubMed ID: 20875323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Calvert GM; Sweeney MH; Fingerhut MA; Hornung RW; Halperin WE
    Am J Ind Med; 1994 Apr; 25(4):559-71. PubMed ID: 7912041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyria cutanea tarda induced by olmesartan.
    Mas-Vidal A; Coto-Segura P; García-Varona A; Santos-Juanes J
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):977-8. PubMed ID: 20015057
    [No Abstract]   [Full Text] [Related]  

  • 10. Porphyria cutanea tarda: pregnancy versus estrogen effect.
    Urbanek RW; Cohen DJ
    J Am Acad Dermatol; 1994 Aug; 31(2 Pt 2):390-2. PubMed ID: 7913477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda in a child following multi-agent chemotherapy.
    LaPresto L; Nyanda H; Knapp CF; Sopkovich J; Nelson CG
    J Drugs Dermatol; 2014 Apr; 13(4):489-91. PubMed ID: 24719070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Porphyria cutanea tarda in a patient presenting hepatitis C treated with imatinib].
    Chraïbi R; Labeille B; Perrot JL; Cambazard F
    Ann Dermatol Venereol; 2008 Nov; 135(11):775-6. PubMed ID: 19061660
    [No Abstract]   [Full Text] [Related]  

  • 13. Sclerodermatous changes revealing porphyria cutanea tarda.
    Castanet J; Lacour JP; Perrin C; Guidoni JF; Ortonne JP
    Acta Derm Venereol; 1994 Jul; 74(4):310-1. PubMed ID: 7976096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria cutanea tarda affecting lower lip.
    Martínez A; Morales R; Brethauer U; Jiménez M; Alarcón R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):705-8. PubMed ID: 11113814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.
    Roberts AG; Elder GH; De Salamanca RE; Herrero C; Lecha M; Mascaro JM
    J Invest Dermatol; 1995 Apr; 104(4):500-2. PubMed ID: 7706766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda and melioidosis.
    Fung WK; Tam SC; Ho KM; Lam P; Lo KK
    Hong Kong Med J; 2001 Jun; 7(2):197-200. PubMed ID: 11514757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized morphoea secondary to porphyria cutanea tarda.
    Stevens HP; Ostlere LS; Black CM; Rustin MH
    Br J Dermatol; 1993 Oct; 129(4):455-7. PubMed ID: 8105868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyria cutanea tarda induced by estrogens.
    Becker FT
    Arch Dermatol; 1965 Sep; 92(3):252-5; discussion 255-6. PubMed ID: 11851245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen-related porphyria cutanea tarda.
    Agarwal R; Peters TJ; Coombes RC; Vigushin DM
    Med Oncol; 2002; 19(2):121-3. PubMed ID: 12180481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-thalassaemia minor and porphyria cutanea tarda.
    McKenna KE; Dawson JF
    Br J Dermatol; 1992 Oct; 127(4):401-2. PubMed ID: 1358169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.